这个报告强调了关于国际调度控制受管制药物的失败,并提出确保以健康和证据为基础的体系的重要建议。 英文版本拥有更多信息,请阅读下文。

通过订阅IDPC每月警报, 随时掌握与药物政策发展相关的最新信息。


While often viewed as an obscure technical issue, the problem of scheduling lies at the core of the functioning of the international drug control system.

Scheduling – the classification of a substance within a graded system of controls and restrictions, or 'schedules' – must take place in order for a substance to be included in the international control framework, and determines the type and intensity of controls to be applied.

The issue has become a contemporary flashpoint for strains and tensions surrounding the general orientation of the present regime of drug control and the international Conventions which reside at its heart.

The approaching United Nations General Assembly Special Session (UNGASS) on 'the world drug problem' of 2016 may provide an opportunity for the re-examination of current theory and practice in relation to scheduling, and to the elaboration of improved arrangements.6 Amongst the most prominent of present stresses are disputes surrounding the proper role of UN drug control bodies in the scheduling process – especially those of the International Narcotics Control Board (INCB) and the WHO. However, we will suggest that the part played by the CND and states parties is also fraught with difficulties.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.